Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global IPV Vaccine Market Growth 2022-2028

  • LP 4968281
  • 91 Pages
  • June 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of IPV Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global IPV Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global IPV Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States IPV Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global IPV Vaccine market, reaching US$ million by the year 2028. As for the Europe IPV Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main IPV Vaccine players cover GlaxoSmithKline Plc, Sanofi S.A, Serum Institute of India Pvt. Ltd., and PT Bio Farma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of IPV Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Mahoney

MEF1

Saukett

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Private Distribution Channel

Public Distribution Channel

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

GlaxoSmithKline Plc

Sanofi S.A

Serum Institute of India Pvt. Ltd.

PT Bio Farma

AJ Vaccines

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global IPV Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for IPV Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for IPV Vaccine by Country/Region, 2017, 2022 & 2028

2.2 IPV Vaccine Segment by Type

2.2.1 Mahoney

2.2.2 MEF1

2.2.3 Saukett

2.3 IPV Vaccine Sales by Type

2.3.1 Global IPV Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global IPV Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global IPV Vaccine Sale Price by Type (2017-2022)

2.4 IPV Vaccine Segment by Application

2.4.1 Private Distribution Channel

2.4.2 Public Distribution Channel

2.5 IPV Vaccine Sales by Application

2.5.1 Global IPV Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global IPV Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global IPV Vaccine Sale Price by Application (2017-2022)

3 Global IPV Vaccine by Company

3.1 Global IPV Vaccine Breakdown Data by Company

3.1.1 Global IPV Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global IPV Vaccine Sales Market Share by Company (2020-2022)

3.2 Global IPV Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global IPV Vaccine Revenue by Company (2020-2022)

3.2.2 Global IPV Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global IPV Vaccine Sale Price by Company

3.4 Key Manufacturers IPV Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers IPV Vaccine Product Location Distribution

3.4.2 Players IPV Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for IPV Vaccine by Geographic Region

4.1 World Historic IPV Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global IPV Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global IPV Vaccine Annual Revenue by Geographic Region

4.2 World Historic IPV Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global IPV Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global IPV Vaccine Annual Revenue by Country/Region

4.3 Americas IPV Vaccine Sales Growth

4.4 APAC IPV Vaccine Sales Growth

4.5 Europe IPV Vaccine Sales Growth

4.6 Middle East & Africa IPV Vaccine Sales Growth

5 Americas

5.1 Americas IPV Vaccine Sales by Country

5.1.1 Americas IPV Vaccine Sales by Country (2017-2022)

5.1.2 Americas IPV Vaccine Revenue by Country (2017-2022)

5.2 Americas IPV Vaccine Sales by Type

5.3 Americas IPV Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC IPV Vaccine Sales by Region

6.1.1 APAC IPV Vaccine Sales by Region (2017-2022)

6.1.2 APAC IPV Vaccine Revenue by Region (2017-2022)

6.2 APAC IPV Vaccine Sales by Type

6.3 APAC IPV Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe IPV Vaccine by Country

7.1.1 Europe IPV Vaccine Sales by Country (2017-2022)

7.1.2 Europe IPV Vaccine Revenue by Country (2017-2022)

7.2 Europe IPV Vaccine Sales by Type

7.3 Europe IPV Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa IPV Vaccine by Country

8.1.1 Middle East & Africa IPV Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa IPV Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa IPV Vaccine Sales by Type

8.3 Middle East & Africa IPV Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of IPV Vaccine

10.3 Manufacturing Process Analysis of IPV Vaccine

10.4 Industry Chain Structure of IPV Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 IPV Vaccine Distributors

11.3 IPV Vaccine Customer

12 World Forecast Review for IPV Vaccine by Geographic Region

12.1 Global IPV Vaccine Market Size Forecast by Region

12.1.1 Global IPV Vaccine Forecast by Region (2023-2028)

12.1.2 Global IPV Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global IPV Vaccine Forecast by Type

12.7 Global IPV Vaccine Forecast by Application

13 Key Players Analysis

13.1 GlaxoSmithKline Plc

13.1.1 GlaxoSmithKline Plc Company Information

13.1.2 GlaxoSmithKline Plc IPV Vaccine Product Offered

13.1.3 GlaxoSmithKline Plc IPV Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GlaxoSmithKline Plc Main Business Overview

13.1.5 GlaxoSmithKline Plc Latest Developments

13.2 Sanofi S.A

13.2.1 Sanofi S.A Company Information

13.2.2 Sanofi S.A IPV Vaccine Product Offered

13.2.3 Sanofi S.A IPV Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi S.A Main Business Overview

13.2.5 Sanofi S.A Latest Developments

13.3 Serum Institute of India Pvt. Ltd.

13.3.1 Serum Institute of India Pvt. Ltd. Company Information

13.3.2 Serum Institute of India Pvt. Ltd. IPV Vaccine Product Offered

13.3.3 Serum Institute of India Pvt. Ltd. IPV Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Serum Institute of India Pvt. Ltd. Main Business Overview

13.3.5 Serum Institute of India Pvt. Ltd. Latest Developments

13.4 PT Bio Farma

13.4.1 PT Bio Farma Company Information

13.4.2 PT Bio Farma IPV Vaccine Product Offered

13.4.3 PT Bio Farma IPV Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 PT Bio Farma Main Business Overview

13.4.5 PT Bio Farma Latest Developments

13.5 AJ Vaccines

13.5.1 AJ Vaccines Company Information

13.5.2 AJ Vaccines IPV Vaccine Product Offered

13.5.3 AJ Vaccines IPV Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 AJ Vaccines Main Business Overview

13.5.5 AJ Vaccines Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. IPV Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. IPV Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Mahoney

Table 4. Major Players of MEF1

Table 5. Major Players of Saukett

Table 6. Global IPV Vaccine Sales by Type (2017-2022) & (Units)

Table 7. Global IPV Vaccine Sales Market Share by Type (2017-2022)

Table 8. Global IPV Vaccine Revenue by Type (2017-2022) & ($ million)

Table 9. Global IPV Vaccine Revenue Market Share by Type (2017-2022)

Table 10. Global IPV Vaccine Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global IPV Vaccine Sales by Application (2017-2022) & (Units)

Table 12. Global IPV Vaccine Sales Market Share by Application (2017-2022)

Table 13. Global IPV Vaccine Revenue by Application (2017-2022)

Table 14. Global IPV Vaccine Revenue Market Share by Application (2017-2022)

Table 15. Global IPV Vaccine Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global IPV Vaccine Sales by Company (2020-2022) & (Units)

Table 17. Global IPV Vaccine Sales Market Share by Company (2020-2022)

Table 18. Global IPV Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 19. Global IPV Vaccine Revenue Market Share by Company (2020-2022)

Table 20. Global IPV Vaccine Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers IPV Vaccine Producing Area Distribution and Sales Area

Table 22. Players IPV Vaccine Products Offered

Table 23. IPV Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global IPV Vaccine Sales by Geographic Region (2017-2022) & (Units)

Table 27. Global IPV Vaccine Sales Market Share Geographic Region (2017-2022)

Table 28. Global IPV Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global IPV Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global IPV Vaccine Sales by Country/Region (2017-2022) & (Units)

Table 31. Global IPV Vaccine Sales Market Share by Country/Region (2017-2022)

Table 32. Global IPV Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global IPV Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas IPV Vaccine Sales by Country (2017-2022) & (Units)

Table 35. Americas IPV Vaccine Sales Market Share by Country (2017-2022)

Table 36. Americas IPV Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas IPV Vaccine Revenue Market Share by Country (2017-2022)

Table 38. Americas IPV Vaccine Sales by Type (2017-2022) & (Units)

Table 39. Americas IPV Vaccine Sales Market Share by Type (2017-2022)

Table 40. Americas IPV Vaccine Sales by Application (2017-2022) & (Units)

Table 41. Americas IPV Vaccine Sales Market Share by Application (2017-2022)

Table 42. APAC IPV Vaccine Sales by Region (2017-2022) & (Units)

Table 43. APAC IPV Vaccine Sales Market Share by Region (2017-2022)

Table 44. APAC IPV Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC IPV Vaccine Revenue Market Share by Region (2017-2022)

Table 46. APAC IPV Vaccine Sales by Type (2017-2022) & (Units)

Table 47. APAC IPV Vaccine Sales Market Share by Type (2017-2022)

Table 48. APAC IPV Vaccine Sales by Application (2017-2022) & (Units)

Table 49. APAC IPV Vaccine Sales Market Share by Application (2017-2022)

Table 50. Europe IPV Vaccine Sales by Country (2017-2022) & (Units)

Table 51. Europe IPV Vaccine Sales Market Share by Country (2017-2022)

Table 52. Europe IPV Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe IPV Vaccine Revenue Market Share by Country (2017-2022)

Table 54. Europe IPV Vaccine Sales by Type (2017-2022) & (Units)

Table 55. Europe IPV Vaccine Sales Market Share by Type (2017-2022)

Table 56. Europe IPV Vaccine Sales by Application (2017-2022) & (Units)

Table 57. Europe IPV Vaccine Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa IPV Vaccine Sales by Country (2017-2022) & (Units)

Table 59. Middle East & Africa IPV Vaccine Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa IPV Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa IPV Vaccine Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa IPV Vaccine Sales by Type (2017-2022) & (Units)

Table 63. Middle East & Africa IPV Vaccine Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa IPV Vaccine Sales by Application (2017-2022) & (Units)

Table 65. Middle East & Africa IPV Vaccine Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of IPV Vaccine

Table 67. Key Market Challenges & Risks of IPV Vaccine

Table 68. Key Industry Trends of IPV Vaccine

Table 69. IPV Vaccine Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. IPV Vaccine Distributors List

Table 72. IPV Vaccine Customer List

Table 73. Global IPV Vaccine Sales Forecast by Region (2023-2028) & (Units)

Table 74. Global IPV Vaccine Sales Market Forecast by Region

Table 75. Global IPV Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global IPV Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas IPV Vaccine Sales Forecast by Country (2023-2028) & (Units)

Table 78. Americas IPV Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC IPV Vaccine Sales Forecast by Region (2023-2028) & (Units)

Table 80. APAC IPV Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe IPV Vaccine Sales Forecast by Country (2023-2028) & (Units)

Table 82. Europe IPV Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa IPV Vaccine Sales Forecast by Country (2023-2028) & (Units)

Table 84. Middle East & Africa IPV Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global IPV Vaccine Sales Forecast by Type (2023-2028) & (Units)

Table 86. Global IPV Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 87. Global IPV Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global IPV Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global IPV Vaccine Sales Forecast by Application (2023-2028) & (Units)

Table 90. Global IPV Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 91. Global IPV Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global IPV Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 93. GlaxoSmithKline Plc Basic Information, IPV Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 94. GlaxoSmithKline Plc IPV Vaccine Product Offered

Table 95. GlaxoSmithKline Plc IPV Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. GlaxoSmithKline Plc Main Business

Table 97. GlaxoSmithKline Plc Latest Developments

Table 98. Sanofi S.A Basic Information, IPV Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 99. Sanofi S.A IPV Vaccine Product Offered

Table 100. Sanofi S.A IPV Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Sanofi S.A Main Business

Table 102. Sanofi S.A Latest Developments

Table 103. Serum Institute of India Pvt. Ltd. Basic Information, IPV Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 104. Serum Institute of India Pvt. Ltd. IPV Vaccine Product Offered

Table 105. Serum Institute of India Pvt. Ltd. IPV Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Serum Institute of India Pvt. Ltd. Main Business

Table 107. Serum Institute of India Pvt. Ltd. Latest Developments

Table 108. PT Bio Farma Basic Information, IPV Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 109. PT Bio Farma IPV Vaccine Product Offered

Table 110. PT Bio Farma IPV Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. PT Bio Farma Main Business

Table 112. PT Bio Farma Latest Developments

Table 113. AJ Vaccines Basic Information, IPV Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 114. AJ Vaccines IPV Vaccine Product Offered

Table 115. AJ Vaccines IPV Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. AJ Vaccines Main Business

Table 117. AJ Vaccines Latest Developments

List of Figures

Figure 1. Picture of IPV Vaccine

Figure 2. IPV Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global IPV Vaccine Sales Growth Rate 2017-2028 (Units)

Figure 7. Global IPV Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. IPV Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Mahoney

Figure 10. Product Picture of MEF1

Figure 11. Product Picture of Saukett

Figure 12. Global IPV Vaccine Sales Market Share by Type in 2021

Figure 13. Global IPV Vaccine Revenue Market Share by Type (2017-2022)

Figure 14. IPV Vaccine Consumed in Private Distribution Channel

Figure 15. Global IPV Vaccine Market: Private Distribution Channel (2017-2022) & (Units)

Figure 16. IPV Vaccine Consumed in Public Distribution Channel

Figure 17. Global IPV Vaccine Market: Public Distribution Channel (2017-2022) & (Units)

Figure 18. Global IPV Vaccine Sales Market Share by Application (2017-2022)

Figure 19. Global IPV Vaccine Revenue Market Share by Application in 2021

Figure 20. IPV Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 21. Global IPV Vaccine Revenue Market Share by Company in 2021

Figure 22. Global IPV Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global IPV Vaccine Revenue Market Share by Geographic Region in 2021

Figure 24. Global IPV Vaccine Sales Market Share by Region (2017-2022)

Figure 25. Global IPV Vaccine Revenue Market Share by Country/Region in 2021

Figure 26. Americas IPV Vaccine Sales 2017-2022 (Units)

Figure 27. Americas IPV Vaccine Revenue 2017-2022 ($ Millions)

Figure 28. APAC IPV Vaccine Sales 2017-2022 (Units)

Figure 29. APAC IPV Vaccine Revenue 2017-2022 ($ Millions)

Figure 30. Europe IPV Vaccine Sales 2017-2022 (Units)

Figure 31. Europe IPV Vaccine Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa IPV Vaccine Sales 2017-2022 (Units)

Figure 33. Middle East & Africa IPV Vaccine Revenue 2017-2022 ($ Millions)

Figure 34. Americas IPV Vaccine Sales Market Share by Country in 2021

Figure 35. Americas IPV Vaccine Revenue Market Share by Country in 2021

Figure 36. United States IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC IPV Vaccine Sales Market Share by Region in 2021

Figure 41. APAC IPV Vaccine Revenue Market Share by Regions in 2021

Figure 42. China IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. India IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe IPV Vaccine Sales Market Share by Country in 2021

Figure 49. Europe IPV Vaccine Revenue Market Share by Country in 2021

Figure 50. Germany IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. France IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa IPV Vaccine Sales Market Share by Country in 2021

Figure 56. Middle East & Africa IPV Vaccine Revenue Market Share by Country in 2021

Figure 57. Egypt IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country IPV Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of IPV Vaccine in 2021

Figure 63. Manufacturing Process Analysis of IPV Vaccine

Figure 64. Industry Chain Structure of IPV Vaccine

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390